<?xml version="1.0" encoding="UTF-8"?>
<p id="par0115">Test rats administered AESG 1000 mg/kg recorded significant increase (
 <italic>P &lt; 0.05</italic>) in plasma urea concentration; whereas the plasma urea levels of rats given AESG 500 and 2000 mg/, respectively, were not significantly different (
 <italic>P &lt; 0.05</italic>), relative to the plasma urea concentration of the control (
 <xref rid="fig0035" ref-type="fig">Fig. 7</xref>). The plasma creatinine levels of rats administered AESG was not significantly different (
 <italic>P &lt; 0.05</italic>) when compared to the control (
 <xref rid="fig0035" ref-type="fig">Fig. 7</xref>). There was a significant reduction (
 <italic>P &lt; 0.05</italic>) in plasma Na
 <sup>+</sup> concentration of test rats administered AESG 2000 mg/kg; whereas the plasma sodium ions of rats administered AESG 500 and 1000 mg/kg, respectively, were not significantly different (
 <italic>P &lt; 0.05</italic>), relative to the control (
 <xref rid="fig0040" ref-type="fig">Fig. 8</xref>). The plasma chloride and potassium ion concentrations of rats administered AESG were not significantly different (
 <italic>P &lt; 0.05</italic>), relative to the control (
 <xref rid="fig0040" ref-type="fig">Fig. 8</xref>). There were no significant differences (
 <italic>P &lt; 0.05</italic>) in plasma “corrected” calcium of test animals given AESG 500 and 2000 mg/kg, respectively; whereas rats administered AESG 1000 mg/kg recorded significant reduction (
 <italic>P &lt; 0.05</italic>) in plasma “corrected” calcium concentration, relative to the control (
 <xref rid="fig0045" ref-type="fig">Fig. 9</xref>). Test animals administered AESG 500 mg/kg recorded a significant reduction (
 <italic>P &lt; 0.05</italic>) in plasma bicarbonate ion concentration; whereas rats given AESG 1000 and 2000 mg/kg, respectively, were not significantly different (
 <italic>P &lt; 0.05</italic>) compared to the control (
 <xref rid="fig0045" ref-type="fig">Fig. 9</xref>).
</p>
